Skip to content
OpenCapital
Get started

Guardant Health GH Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$301.7MBeat by $22.5MDiluted EPS-$0.85Miss by $0.38
Revenue estimate$279.2M
EPS estimate-$0.47

Next report

Jul 29, 2026 (In 2 weeks)
Revenue estimate$314.2M
EPS estimate-$0.41

Financials

Q1 2026

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation & ratios

Valuation

as of 07/09/26
See full
Market cap$20.71B+130%
Enterprise value$21.31B+121%
P/S19.2×+7.6×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Current ratio4.7×+0.6×

Segments

By product

See full
Oncology$205.0M+36.1%
Biopharma and data$53.0M+16.8%
Screening$41.6M+633%
Licensing and other$2.1M+15.3%

By segment

See full
Reportable Segment$301.7M+48.3%

Versus estimates

Revenue

Q1 2026$301.7MBeat by $22.5M
Q4 2025$281.3MBeat by $8.8MQ3 2025$265.2MMiss by $2.4MQ2 2025$232.1MMiss by $3.6MQ1 2025$203.5MMiss by $8.0MQ4 2024$201.8MBeat by $9.3M

Diluted EPS

Q1 2026-$0.85Miss by $0.38
Q4 2025-$0.90Miss by $0.13Q3 2025-$0.39Beat by $0.09Q2 2025-$0.44Beat by $0.08Q1 2025-$0.49Beat by $0.12Q4 2024-$0.62Beat by $0.13

Ask the moment Guardant Health reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Guardant Health report Q1 2026 earnings?
Guardant Health (GH) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Guardant Health's Q1 2026 revenue and EPS?
Guardant Health reported revenue of $301.7M and diluted EPS of $-0.85 for Q1 2026.
Did Guardant Health beat estimates in Q1 2026?
Revenue beat the consensus estimate of $279.2M by $22.5M. EPS missed the consensus estimate of $-0.47 by $0.38.
How did Guardant Health's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 48.3% from $203.5M a year earlier and diluted EPS declined 73.5% from $-0.49.
Where can I find Guardant Health's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001576280-26-000024) and the 10-Q periodic report (0001576280-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.